Expression of the gangliosides GD3 and GD2 on lymphocytes in tissue sections of melanoma
- 31 December 1988
- Vol. 21 (1) , 51-58
- https://doi.org/10.3109/00313028909059531
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanomaInternational Journal of Cancer, 1988
- Immunohistological evaluation of MHC class I and II antigen expression on nevi and melanoma: relation to biology of melanomaPathology, 1987
- GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progressionFEBS Letters, 1986
- Pigmentation-Associated Glycoprotein of Human Melanomas and Melanocytes: Definition with a Mouse Monoclonal AntibodyJournal of Investigative Dermatology, 1985
- Kinetics of activation antigen expression by in vitro-stimulated human T lymphocytesCellular Immunology, 1985
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- GM3 ganglioside induces hamster fibrobiast growth inhibition in chemically-defined medium: Ganglioside may regulate growth factor receptor functionBiochemical and Biophysical Research Communications, 1982
- GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.The Journal of Experimental Medicine, 1982
- A human leukocyte antigen identified by a monoclonal antibodyHuman Immunology, 1981
- Biosynthesis and Function of GangliosidesScience, 1976